FDA approves new silicone gel-filled breast implant

FDA approves new silicone gel-filled breast implant
The Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant has been approved by the U.S. Food and Drug Administration for breast augmentation in women aged 22 years or older and for reconstruction in women of all ages.

(HealthDay)—The Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Gel Filled Breast Implant has been approved by the U.S. Food and Drug Administration for breast augmentation in women aged 22 years or older and for reconstruction in women of all ages.

The FDA approval was based on data from 941 women followed for seven years. Complications included capsular contracture, re-operation, implant removal, asymmetry, and infection, most of which have been identified in previous breast implant studies. In addition, gel fractures or fissures were observed in the gel of some Natrelle 410 implants.

The FDA has required that the manufacturer, Allergan, conduct post-approval studies, including a five-year follow-up involving about 3,500 women who received the implants as part of the company's access study; a 10-year follow-up of more than 2,000 women to identify long-term complications; and five case-control studies to examine the correlation of the implants with . They have also required an assessment of women's perceptions of the patient labeling and analysis of implants removed from patients and returned to the manufacturer.

The implant is manufactured by Allergan Inc., based in Irvine, Calif.

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

Consumer group questions review of breast implants

Jan 05, 2012

(AP) -- Consumer safety advocates are questioning the Food and Drug Administration about seemingly incomplete and erroneous data used to affirm the safety of silicone breast implants last year.

FDA: Breast implant problems grow with time

Jun 22, 2011

Don't expect breast implants to last for life, the government warned Wednesday: About 1 in 5 women who receive them for cosmetic reasons will have them removed within 10 years, and those odds are even higher ...

Australia: No higher risk from French implants

Jan 05, 2012

(AP) -- Australian health officials said they have found no evidence that potentially faulty French-made breast implants are at an increased risk of rupture in Australian women.

Recommended for you

Experts: Chopin's heart shows signs of TB

21 hours ago

The preserved heart of composer Frederic Chopin contains signs of tuberculosis and possibly some other lung disease, medical experts said Wednesday.

The argument in favor of doping

23 hours ago

Ahead of Friday's court ruling on whether ASADA's investigation into the Essendon Football Club was lawful, world leader in practical and medical ethics Professor Julian Savulescu, looks at whether there is a role for performance-enhancing ...

Errata frequently seen in medical literature

Sep 16, 2014

(HealthDay)—Errata, including those that may materially change the interpretation of data, are frequent in medical publications, according to a study published in the August issue of The American Journal of ...

User comments